Midmark Corp., a leading medical solutions provider for ambulatory care, today announced a new partnership with HEINE, a global leader and German manufacturer of medical diagnostic instruments for early detection of diseases. Beginning in January 2018, Midmark and HEINE will work together to provide customers in the United States medical market with three types of high quality diagnostic instruments: otoscopes, ophthalmoscopes and manual sphygmomanometers.
As the U.S. healthcare market continues to evolve and place growing importance on improving patient outcomes, clinicians are rethinking the importance of using the latest diagnostic instrument technologies for early, accurate diagnosis and treatment. With HEINE expertise as a world leader in diagnostic instrument technology and Midmark expertise in bringing together knowledge of the clinical space, technology and workflow, the partnership is a natural fit.
“For more than 70 years, HEINE customers around the world have relied on the company’s commitment to offering the highest quality diagnostic instruments to help clinicians make the earliest and most accurate diagnosis,” said John Baumann, president and CEO, Midmark. “Midmark and HEINE share a deep commitment to our employees and customers, striving to provide exceptional products and leading the industry in development of innovative technologies. As we look for new ways to support our customers, this partnership allows us to leverage the strength of both companies to support the non-acute market with our distribution partners and offer our customers a single, trusted source for nearly all exam room equipment.”
Based in Germany, HEINE is a vertically integrated company with a high level of control over manufacturing processes and product quality. From the initial concept to the finished product, nearly all processes are completed in-house at HEINE facilities in Germany, ensuring Midmark and HEINE customers with high quality, lasting and durable products.
“Many non-acute care clinicians in the United States may not even realize there are options available for this type of diagnostic equipment,” said Oliver Heine, CEO, HEINE Optotechnik. “We have an opportunity to educate customers on the benefits of seeing more clearly for exams at the point of care – and provide a solution that ultimately improves diagnosis and treatment for patients. We’re looking forward to working with Midmark to serve the U.S. healthcare market.”
More information about the partnership between Midmark and HEINE, as well as the co-branded diagnostic equipment, will be available on midmark.com in January 2018.
IAQ and Infection Mitigation: Plans Into Actions
Case Study: How NYU Langone Rebuilt for Resilience After Superstorm Sandy
Dayton Children's Hospital Announces New Rehabilitative Services Building
The Debate on Laundering Microfibers in Healthcare
Construction Begins for New Cancer Center at OhioHealth's Administrative Campus